STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/8f1dcd4a5b4e48c8e4ab222287ec8ad8f105c03e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about another Novartis trial failure, a Novo Nordisk setback, and more"></iframe>